7Baggers

Bausch Health Companies Quarterly Balance Sheets Chart

Quarterly
 | 
Annual
 
 Goodwill  
 Cash and Cash Eq  
 Account Payables  
 Inventory  
20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 20240630 20240930 20241231 20250331 20250630 01.883.765.647.529.411.2813.16Billion

Bausch Health Companies Quarterly Balance Sheets Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-06-30 2015-09-30 2013-09-30 2013-06-30 2012-09-30 2012-06-30 
                                          
  assets                                        
  current assets:                                        
  cash and cash equivalents1,727,000,000 1,134,000,000 1,181,000,000 719,000,000 595,000,000 733,000,000 947,000,000 760,000,000 579,000,000 518,000,000 564,000,000 486,000,000 659,000,000 1,249,000,000 582,000,000 690,000,000 642,000,000 679,000,000 605,000,000 977,000,000 896,000,000 912,000,000 3,243,000,000 825,000,000 878,000,000 782,000,000 721,000,000 973,000,000 838,000,000 909,000,000 720,000,000 964,000,000 1,214,000,000 1,210,000,000 852,400,000 1,420,000,000 596,347,000 2,539,390,000 257,730,000 395,266,000 
  restricted cash16,000,000 23,000,000 20,000,000 31,000,000 28,000,000 22,000,000  20,000,000 9,000,000 13,000,000      1,214,000,000 1,214,000,000 1,214,000,000 1,211,000,000 1,011,000,000 1,011,000,000 1,011,000,000 1,000,000 2,000,000 2,000,000 2,000,000 2,000,000    77,000,000 928,000,000 811,000,000      8,231,000 8,598,000 
  trade receivables2,210,000,000 2,072,000,000 2,140,000,000 2,094,000,000 2,102,000,000 2,048,000,000 1,998,000,000 1,948,000,000 1,743,000,000 1,688,000,000 1,790,000,000 1,739,000,000 1,645,000,000 1,566,000,000 1,775,000,000 1,730,000,000 1,609,000,000 1,499,000,000 1,577,000,000 1,733,000,000 1,369,000,000 1,712,000,000 1,839,000,000 1,747,000,000 1,829,000,000 1,786,000,000 1,865,000,000 2,041,000,000 1,973,000,000 1,940,000,000 2,130,000,000 2,229,000,000 2,096,000,000 2,097,000,000 2,732,500,000 2,696,300,000     
  inventories1,655,000,000 1,613,000,000 1,595,000,000 1,655,000,000 1,612,000,000 1,636,000,000 1,544,000,000 1,272,000,000 1,240,000,000 1,222,000,000 1,090,000,000 1,056,000,000 1,073,000,000 1,045,000,000 993,000,000 1,058,000,000 1,086,000,000 1,076,000,000 1,094,000,000 1,224,000,000 1,226,000,000 1,124,000,000 1,107,000,000 1,100,000,000 1,060,000,000 1,012,000,000 934,000,000 971,000,000 993,000,000 1,042,000,000 1,048,000,000 1,071,000,000 1,084,000,000 1,111,000,000 1,336,700,000 1,199,200,000 1,076,088,000 497,059,000 418,252,000 388,729,000 
  prepaid expenses and other current assets906,000,000 890,000,000 838,000,000 852,000,000 874,000,000 957,000,000 1,092,000,000 1,048,000,000 890,000,000 796,000,000 776,000,000 718,000,000 820,000,000 765,000,000 720,000,000 632,000,000 899,000,000 924,000,000 855,000,000 726,000,000 776,000,000 745,000,000 779,000,000 631,000,000 698,000,000 693,000,000 689,000,000 757,000,000 835,000,000 833,000,000 771,000,000 736,000,000 710,000,000 675,000,000 896,800,000 953,000,000 257,389,000 115,497,000 72,214,000 56,470,000 
  total current assets6,514,000,000 5,732,000,000 5,774,000,000 5,351,000,000 5,211,000,000 5,396,000,000 5,596,000,000 5,048,000,000 4,461,000,000 4,237,000,000 4,247,000,000 4,010,000,000 5,417,000,000 5,836,000,000 5,607,000,000 5,324,000,000 5,450,000,000 5,392,000,000 5,342,000,000 5,671,000,000 5,278,000,000 5,504,000,000 6,969,000,000 4,305,000,000 4,467,000,000 4,275,000,000 4,211,000,000 4,742,000,000 4,639,000,000 4,724,000,000 4,746,000,000 5,944,000,000 5,992,000,000 5,333,000,000 5,818,400,000 6,995,700,000 3,848,363,000 4,532,026,000 1,713,670,000 1,630,234,000 
  property, plant and equipment1,994,000,000 1,882,000,000 1,780,000,000 1,789,000,000 1,738,000,000 1,713,000,000 1,707,000,000 1,584,000,000 1,599,000,000 1,596,000,000 1,600,000,000 1,507,000,000 1,545,000,000 1,579,000,000 1,598,000,000 1,584,000,000 1,590,000,000 1,556,000,000 1,567,000,000 1,550,000,000 1,496,000,000 1,450,000,000 1,466,000,000 1,390,000,000 1,372,000,000 1,341,000,000 1,353,000,000 1,341,000,000 1,355,000,000 1,411,000,000 1,403,000,000 1,398,000,000 1,373,000,000 1,328,000,000 1,472,100,000 1,351,400,000 1,221,606,000 440,998,000 450,327,000 409,399,000 
  intangible assets5,047,000,000 5,297,000,000 5,551,000,000 5,652,000,000 5,903,000,000 6,183,000,000 6,456,000,000 6,728,000,000 5,299,000,000 5,552,000,000 5,800,000,000 6,024,000,000 6,322,000,000 6,632,000,000 6,948,000,000 7,258,000,000 7,624,000,000 7,997,000,000 8,445,000,000 8,923,000,000 9,297,000,000 9,726,000,000 10,201,000,000 10,650,000,000 11,196,000,000 11,683,000,000 12,001,000,000 12,655,000,000 13,393,000,000 14,464,000,000 15,211,000,000 16,023,000,000 17,516,000,000 18,186,000,000 21,335,800,000 22,382,100,000 13,090,339,000 9,289,669,000 8,035,717,000 8,121,556,000 
  goodwill11,298,000,000 11,153,000,000 11,087,000,000 11,171,000,000 11,127,000,000 11,160,000,000 11,183,000,000 11,187,000,000 11,628,000,000 11,579,000,000 11,547,000,000 12,044,000,000 12,266,000,000 12,427,000,000 12,457,000,000 12,477,000,000 12,527,000,000 12,485,000,000 13,044,000,000 13,160,000,000 13,084,000,000 13,034,000,000 13,126,000,000 13,052,000,000 13,160,000,000 13,121,000,000 13,142,000,000 13,290,000,000 13,283,000,000 13,432,000,000 15,593,000,000 15,573,000,000 15,892,000,000 15,753,000,000 18,511,800,000 17,374,700,000 9,742,003,000 5,277,798,000 3,799,613,000 3,724,341,000 
  deferred tax assets2,025,000,000 1,977,000,000 1,968,000,000 2,188,000,000 2,187,000,000 2,149,000,000 2,101,000,000 2,189,000,000 2,191,000,000 2,163,000,000 2,166,000,000 2,372,000,000 2,283,000,000 2,282,000,000 2,252,000,000 2,266,000,000 2,255,000,000 2,150,000,000 2,137,000,000 1,913,000,000 1,874,000,000 1,740,000,000 1,690,000,000 1,868,000,000 1,799,000,000 1,754,000,000 1,676,000,000 1,641,000,000 1,654,000,000 1,660,000,000 433,000,000 166,000,000 140,000,000 142,000,000 304,700,000 727,200,000 221,934,000 198,674,000 150,539,000 150,362,000 
  other non-current assets388,000,000 380,000,000 363,000,000 389,000,000 329,000,000 312,000,000 307,000,000 328,000,000 325,000,000 318,000,000 326,000,000 341,000,000 338,000,000 334,000,000 340,000,000 343,000,000 596,000,000 617,000,000 664,000,000 345,000,000 367,000,000 411,000,000 411,000,000 402,000,000 360,000,000 377,000,000 109,000,000 108,000,000 124,000,000 107,000,000 99,000,000 152,000,000 111,000,000 190,000,000       
  total assets27,266,000,000 26,421,000,000 26,523,000,000 26,540,000,000 26,495,000,000 26,913,000,000 27,350,000,000 27,064,000,000 25,503,000,000 25,445,000,000 25,686,000,000 26,298,000,000 28,171,000,000 29,090,000,000 29,202,000,000 29,252,000,000 30,042,000,000 30,197,000,000 31,199,000,000 31,562,000,000 31,396,000,000 31,865,000,000 33,863,000,000 31,667,000,000 32,354,000,000 32,551,000,000 32,492,000,000 33,777,000,000 34,448,000,000 35,798,000,000 37,497,000,000 39,974,000,000 41,733,000,000 42,333,000,000 47,662,200,000 48,454,600,000 28,204,384,000 19,782,258,000 14,146,208,000 14,019,820,000 
  liabilities                                        
  current liabilities:                                        
  accounts payable627,000,000 620,000,000 656,000,000 667,000,000 579,000,000 642,000,000 719,000,000 569,000,000 515,000,000 561,000,000 521,000,000 486,000,000 536,000,000 471,000,000 407,000,000 455,000,000 442,000,000 342,000,000 337,000,000 379,000,000 447,000,000 444,000,000 503,000,000 437,000,000 527,000,000 429,000,000 411,000,000 440,000,000 417,000,000 428,000,000 365,000,000 407,000,000 371,000,000 368,000,000 425,900,000 476,800,000 412,943,000 284,544,000 166,688,000 156,178,000 
  accrued and other current liabilities3,469,000,000 3,354,000,000 3,422,000,000 3,386,000,000 3,338,000,000 3,225,000,000 3,133,000,000 3,119,000,000 3,008,000,000 2,916,000,000 2,988,000,000 2,934,000,000 4,311,000,000 4,303,000,000 4,791,000,000 4,982,000,000 5,075,000,000 4,556,000,000 4,576,000,000 4,353,000,000 4,270,000,000 4,438,000,000 4,511,000,000 3,198,000,000 3,122,000,000 3,255,000,000 3,197,000,000 3,424,000,000 3,427,000,000 3,560,000,000 3,694,000,000 3,396,000,000 3,259,000,000 3,484,000,000 3,335,500,000 3,293,500,000     
  current portion of long-term debt879,000,000 282,000,000 2,674,000,000 453,000,000 452,000,000 538,000,000 450,000,000 536,000,000 444,000,000 446,000,000 432,000,000 411,000,000 150,000,000                     346,000,000 294,100,000 707,000,000 360,964,000 346,875,000 207,688,000 195,154,000 
  total current liabilities4,975,000,000 4,256,000,000 6,752,000,000 4,506,000,000 4,369,000,000 4,405,000,000 4,302,000,000 4,224,000,000 3,967,000,000 3,923,000,000 3,941,000,000 3,831,000,000 4,997,000,000 4,774,000,000 5,198,000,000 5,437,000,000 5,517,000,000 4,898,000,000 4,913,000,000 4,732,000,000 4,718,000,000 4,886,000,000 6,248,000,000 3,735,000,000 3,705,000,000 3,941,000,000 3,836,000,000 4,162,000,000 4,074,000,000 3,990,000,000 4,268,000,000 4,728,000,000 4,465,000,000 4,247,000,000 4,226,400,000 4,650,500,000 2,853,082,000 1,761,818,000 1,158,508,000 1,049,197,000 
  acquisition-related contingent consideration264,000,000 282,000,000 310,000,000 248,000,000 230,000,000 225,000,000 253,000,000 247,000,000 197,000,000 219,000,000 208,000,000 189,000,000 188,000,000 193,000,000 202,000,000 207,000,000 206,000,000 202,000,000 216,000,000 275,000,000 279,000,000 268,000,000 262,000,000 267,000,000 271,000,000 264,000,000 298,000,000 282,000,000 310,000,000 320,000,000 344,000,000 345,000,000 755,000,000 818,000,000 170,900,000 161,600,000 125,524,000 91,029,000 112,274,000 67,115,000 
  non-current portion of long-term debt20,859,000,000 21,228,000,000 18,942,000,000 21,054,000,000 21,208,000,000 21,536,000,000 21,938,000,000 21,894,000,000 20,108,000,000 20,207,000,000 20,334,000,000 20,804,000,000 21,664,000,000 23,168,000,000 22,654,000,000 22,358,000,000 23,439,000,000 23,738,000,000 23,925,000,000 24,343,000,000 24,357,000,000 24,424,000,000 24,661,000,000 23,466,000,000 24,023,000,000 23,924,000,000 24,077,000,000 24,433,000,000 24,858,000,000 25,266,000,000 25,235,000,000 26,216,000,000 27,648,000,000 28,198,000,000       
  deferred tax liabilities144,000,000 134,000,000 128,000,000 169,000,000 170,000,000 170,000,000 163,000,000 213,000,000 215,000,000 205,000,000 202,000,000 422,000,000 545,000,000 552,000,000 529,000,000 513,000,000 516,000,000 520,000,000 528,000,000 650,000,000 694,000,000 690,000,000 705,000,000 879,000,000 884,000,000 880,000,000 885,000,000 1,131,000,000 1,130,000,000 1,139,000,000 1,180,000,000 2,237,000,000 4,273,000,000 4,490,000,000 5,879,200,000 11,600,000 64,191,000 4,363,000 8,786,000 7,525,000 
  other non-current liabilities877,000,000 761,000,000 713,000,000 805,000,000 745,000,000 751,000,000 776,000,000 721,000,000 745,000,000 746,000,000 741,000,000 619,000,000 524,000,000 544,000,000 653,000,000 872,000,000 975,000,000 963,000,000 1,012,000,000 907,000,000 802,000,000 807,000,000 851,000,000 760,000,000 783,000,000 763,000,000 581,000,000 532,000,000 518,000,000 560,000,000 526,000,000 102,000,000 104,000,000 88,000,000       
  total liabilities27,119,000,000 26,661,000,000 26,845,000,000 26,782,000,000 26,722,000,000 27,087,000,000 27,432,000,000 27,299,000,000 25,232,000,000 25,300,000,000 25,426,000,000 25,865,000,000 27,918,000,000 29,231,000,000 29,236,000,000 29,387,000,000 30,653,000,000 30,321,000,000 30,594,000,000 30,907,000,000 30,850,000,000 31,075,000,000 32,727,000,000 29,107,000,000 29,666,000,000 29,772,000,000 29,677,000,000 30,540,000,000 30,890,000,000 31,275,000,000 31,553,000,000 34,552,000,000 37,704,000,000 38,339,000,000 42,259,100,000 41,989,900,000 23,143,194,000 14,079,729,000 10,361,026,000 10,324,389,000 
  commitments and contingencies                                        
  equity                                        
  common shares, no par value, unlimited shares authorized, 369,749,489 and 367,843,058 issued and outstanding at june 30, 2025 and december 31, 2024, respectively10,510,000,000                                        
  additional paid-in capital250,000,000 220,000,000 234,000,000 201,000,000 181,000,000 164,000,000 214,000,000 190,000,000 188,000,000 171,000,000 159,000,000 129,000,000 104,000,000 415,000,000 462,000,000 437,000,000 413,000,000 393,000,000 454,000,000 435,000,000 411,000,000 396,000,000 429,000,000 406,000,000 384,000,000 374,000,000 413,000,000 409,000,000 391,000,000 382,000,000 380,000,000 368,000,000 350,000,000 374,000,000 380,400,000 244,600,000 251,654,000 225,289,000 270,183,000 283,061,000 
  accumulated deficit-9,734,000,000 -9,882,000,000 -9,824,000,000 -9,917,000,000 -9,832,000,000 -9,842,000,000 -9,778,000,000 -9,739,000,000 -9,361,000,000 -9,387,000,000 -9,186,000,000 -8,776,000,000 -9,175,000,000 -9,030,000,000 -8,961,000,000 -9,030,000,000 -9,218,000,000 -8,623,000,000 -8,013,000,000 -7,860,000,000 -7,931,000,000 -7,605,000,000 -7,452,000,000 -5,936,000,000 -5,887,000,000 -5,716,000,000 -5,664,000,000 -5,320,000,000 -4,970,000,000 -4,209,000,000 -2,725,000,000 -3,239,000,000 -4,539,000,000 -4,502,000,000 -3,425,700,000 -2,338,500,000 -3,402,294,000 -2,429,051,000 -2,281,834,000 -2,245,886,000 
  accumulated other comprehensive loss-1,790,000,000 -2,029,000,000 -2,179,000,000 -1,947,000,000 -2,007,000,000 -1,917,000,000 -1,881,000,000 -2,051,000,000 -1,902,000,000 -1,989,000,000 -2,056,000,000 -2,265,000,000 -2,002,000,000 -1,974,000,000 -1,924,000,000 -1,923,000,000 -2,182,000,000 -2,256,000,000 -2,133,000,000 -2,207,000,000 -2,223,000,000 -2,281,000,000 -2,086,000,000 -2,156,000,000 -2,061,000,000 -2,116,000,000 -2,137,000,000 -2,053,000,000 -2,068,000,000 -1,852,000,000 -1,896,000,000 -1,888,000,000 -1,965,000,000 -2,020,000,000 -1,573,700,000 -1,463,400,000 -160,257,000 -343,901,000 -119,838,000 -226,969,000 
  total bausch health companies inc. shareholders’ deficit-764,000,000 -1,183,000,000 -1,279,000,000 -1,174,000,000 -1,175,000,000 -1,115,000,000 -1,022,000,000 -1,180,000,000 -663,000,000 -800,000,000 -692,000,000 -525,000,000 -693,000,000 -216,000,000                           
  noncontrolling interest911,000,000 943,000,000 957,000,000 932,000,000 948,000,000 941,000,000 940,000,000 945,000,000 934,000,000 945,000,000 952,000,000 958,000,000 946,000,000 75,000,000 72,000,000 69,000,000 76,000,000 73,000,000 70,000,000 68,000,000 72,000,000 71,000,000 73,000,000 78,000,000 87,000,000 86,000,000 82,000,000 84,000,000 91,000,000 99,000,000 95,000,000 95,000,000 98,000,000 101,000,000 107,200,000 122,400,000 112,077,000    
  total equity147,000,000        271,000,000 145,000,000 260,000,000 433,000,000 253,000,000      605,000,000 655,000,000 546,000,000 790,000,000 1,136,000,000 2,560,000,000 2,688,000,000 2,779,000,000 2,815,000,000 3,237,000,000 3,558,000,000 4,523,000,000 5,944,000,000 5,422,000,000 4,029,000,000 3,994,000,000 5,403,100,000 6,464,700,000 5,061,190,000    
  total liabilities and equity27,266,000,000        25,503,000,000 25,445,000,000 25,686,000,000 26,298,000,000 28,171,000,000      31,199,000,000 31,562,000,000 31,396,000,000 31,865,000,000 33,863,000,000 31,667,000,000 32,354,000,000 32,551,000,000 32,492,000,000 33,777,000,000 34,448,000,000 35,798,000,000 37,497,000,000 39,974,000,000 41,733,000,000 42,333,000,000 47,662,200,000 48,454,600,000 28,204,384,000    
  deficit                                        
  common shares, no par value, unlimited shares authorized, 369,539,455 and 367,843,058 issued and outstanding at march 31, 2025 and december 31, 2024, respectively 10,508,000,000                                       
  total deficit -240,000,000 -322,000,000 -242,000,000 -227,000,000 -174,000,000        -141,000,000                           
  total liabilities and deficit 26,421,000,000 26,523,000,000 26,540,000,000 26,495,000,000 26,913,000,000        29,090,000,000                           
  common shares, no par value, unlimited shares authorized, 367,843,058 and 365,238,917 issued and outstanding at december 31, 2024 and 2023, respectively  10,490,000,000                                      
  common shares, no par value, unlimited shares authorized, 367,695,267 and 365,238,917 issued and outstanding at september 30, 2024 and december 31, 2023, respectively   10,489,000,000                                     
  common shares, no par value, unlimited shares authorized, 366,985,967 and 365,238,917 issued and outstanding at june 30, 2024 and december 31, 2023, respectively    10,483,000,000                                    
  common shares, no par value, unlimited shares authorized, 366,674,264 and 365,238,917 issued and outstanding at march 31, 2024 and december 31, 2023, respectively     10,480,000,000                                   
  restricted cash and other settlement deposits      15,000,000    27,000,000 11,000,000 1,220,000,000 1,211,000,000 1,537,000,000                          
  (deficit) equity                                        
  common shares, no par value, unlimited shares authorized, 365,238,917 and 361,898,846 issued and outstanding at december 31, 2023 and 2022, respectively      10,423,000,000                                  
  total (deficit) equity      -82,000,000 -235,000,000       -34,000,000 -135,000,000 -611,000,000 -124,000,000                       
  total liabilities and (deficit) equity      27,350,000,000 27,064,000,000       29,202,000,000 29,252,000,000 30,042,000,000 30,197,000,000                       
  common shares, no par value, unlimited shares authorized, 365,043,317 and 361,898,846 issued and outstanding at september 30, 2023 and december 31, 2022, respectively       10,420,000,000                                 
  common shares, no par value, unlimited shares authorized, 364,063,514 and 361,898,846 issued and outstanding at june 30, 2023 and december 31, 2022, respectively        10,412,000,000                                
  common shares, no par value, unlimited shares authorized, 363,607,062 and 361,898,846 issued and outstanding at march 31, 2023 and december 31, 2022, respectively         10,405,000,000                               
  common shares, no par value, unlimited shares authorized, 361,898,846 and 359,405,748 issued and outstanding at december 31, 2022 and 2021, respectively          10,391,000,000                              
  common shares, no par value, unlimited shares authorized, 361,781,292 and 359,405,748 issued and outstanding at september 30, 2022 and december 31, 2021, respectively           10,387,000,000                             
  common shares, no par value, unlimited shares authorized, 361,571,921 and 359,405,748 issued and outstanding at june 30, 2022 and december 31, 2021, respectively            10,380,000,000                            
  common shares, no par value, unlimited shares authorized, 361,331,665 and 359,405,748 issued and outstanding at march 31, 2022 and december 31, 2021, respectively             10,373,000,000                           
  common shares, no par value, unlimited shares authorized, 359,405,748 and 355,422,347 issued and outstanding at december 31, 2021 and 2020, respectively              10,317,000,000                          
  total bausch health companies inc. shareholders’ (deficit) equity              -106,000,000 -204,000,000 -687,000,000 -197,000,000                       
  /s/ joseph c. papa                                        
  joseph c. papa                                        
  chief executive officer                                        
  common shares, no par value, unlimited shares authorized, 359,154,635 and 355,422,347 issued and outstanding at september 30, 2021 and december 31, 2020, respectively               10,312,000,000                         
  common shares, no par value, unlimited shares authorized, 358,653,899 and 355,422,347 issued and outstanding at june 30, 2021 and december 31, 2020, respectively                10,300,000,000                        
  common shares, no par value, unlimited shares authorized, 358,104,438 and 355,422,347 issued and outstanding at march 31, 2021 and december 31, 2020, respectively                 10,289,000,000                       
  current portion of long-term debt and other                    1,000,000 4,000,000 1,234,000,000 100,000,000 56,000,000 257,000,000 228,000,000 298,000,000 230,000,000 2,000,000 209,000,000 925,000,000 813,000,000        
  common shares, no par value, unlimited shares authorized, 355,422,347 and 352,562,636 issued and outstanding at december 31, 2020 and 2019, respectively                  10,227,000,000                      
  total bausch health companies inc. shareholders’ equity                  535,000,000 587,000,000 474,000,000 719,000,000 1,063,000,000 2,482,000,000 2,601,000,000 2,693,000,000 2,733,000,000 3,153,000,000 3,467,000,000            
  common shares, no par value, unlimited shares authorized, 355,026,950 and 352,562,636 issued and outstanding at september 30, 2020 and december 31, 2019, respectively                   10,219,000,000                     
  common shares, no par value, unlimited shares authorized, 354,927,516 and 352,562,636 issued and outstanding at june 30, 2020 and december 31, 2019, respectively                    10,217,000,000                    
  common shares, no par value, unlimited shares authorized, 354,579,990 and 352,562,636 issued and outstanding at march 31, 2020 and december 31, 2019, respectively                     10,209,000,000                   
  common shares, no par value, unlimited shares authorized, 352,562,636 and 349,871,102 issued and outstanding at december 31, 2019 and 2018, respectively                      10,172,000,000                  
  common shares, no par value, unlimited shares authorized, 352,387,430 and 349,871,102 issued and outstanding at september 30, 2019 and december 31, 2018, respectively                       10,168,000,000                 
  common shares, no par value, unlimited shares authorized, 352,248,896 and 349,871,102 issued and outstanding at june 30, 2019 and december 31, 2018, respectively                        10,165,000,000                
  common shares, no par value, unlimited shares authorized, 351,873,984 and 349,871,102 issued and outstanding at march 31, 2019 and december 31, 2018, respectively                         10,151,000,000               
  common shares, no par value, unlimited shares authorized, 349,871,102 and 348,708,567 issued and outstanding at december 31, 2018 and 2017, respectively                          10,121,000,000              
  common shares, no par value, unlimited shares authorized, 349,754,139 and 348,708,567 issued and outstanding at september 30, 2018 and december 31, 2017, respectively                           10,117,000,000             
  common shares, no par value, unlimited shares authorized, 349,600,960 and 348,708,567 issued and outstanding at june 30, 2018 and december 31, 2017, respectively                            10,114,000,000            
  common shares, no par value, unlimited shares authorized, 349,219,074 and 348,708,567 issued and outstanding at march 31, 2018 and december 31, 2017, respectively                             10,103,000,000           
  total valeant pharmaceuticals international, inc. shareholders’ equity                             4,424,000,000 5,849,000,000 5,327,000,000 3,931,000,000 3,893,000,000 5,295,900,000 6,342,300,000 4,949,113,000    
  current assets held for sale                               16,000,000 77,000,000 240,000,000       
  non-current assets held for sale                              12,000,000 718,000,000 709,000,000 1,401,000,000       
  current liabilities held for sale                                22,000,000 49,000,000       
  non-current liabilities held for sale                               461,000,000  48,000,000       
  common shares, no par value, unlimited shares authorized, 348,708,567 and 347,821,606 issued and outstanding at december 31, 2017 and 2016, respectively                              10,090,000,000          
  pension and other benefit liabilities                               198,000,000 201,000,000 197,000,000 191,600,000 221,900,000 230,978,000    
  liabilities for uncertain tax positions                               265,000,000 258,000,000 253,000,000 116,300,000 109,300,000 159,673,000 105,766,000 99,544,000 95,945,000 
  common shares, no par value, unlimited shares authorized, 348,582,556 and 347,821,606 issued and outstanding at september 30, 2017 and december 31, 2016, respectively                               10,086,000,000         
  common shares, no par value, unlimited shares authorized, 348,516,280 and 347,821,606                                        
  issued and outstanding at june 30, 2017 and december 31, 2016, respectively                                10,085,000,000        
  common shares, no par value, unlimited shares authorized, 347,860,891 and 347,821,606                                        
  issued and outstanding at march 31, 2017 and december 31, 2016, respectively                                 10,041,000,000       
  other long-term assets                                  219,400,000 236,100,000 241,952,000 199,436,000 97,469,000 89,511,000 
  long-term debt                                  30,773,200,000 30,176,300,000 17,043,750,000 10,447,230,000 7,422,558,000 7,356,021,000 
  other long-term liabilities                                  168,700,000 209,100,000 163,979,000 161,711,000 123,502,000 123,024,000 
  common shares, no par value, unlimited shares authorized, 343,030,673 and                                        
  342,926,531 issued and outstanding at june 30, 2016 and december 31, 2015, respectively                                  9,914,900,000      
  common shares, no par value, unlimited shares authorized, 343,094,009 and                                        
  334,402,964 issued and outstanding at september 30, 2015 and december 31, 2014, respectively                                   9,899,600,000     
  accounts receivable                                    1,643,148,000 1,127,006,000 805,010,000 611,204,000 
  assets held for sale                                    53,457,000 54,400,000 9,925,000 28,203,000 
  accrued liabilities and other current liabilities                                    1,889,460,000 1,035,007,000 634,722,000 600,657,000 
  common shares, no par value, unlimited shares authorized, 332,757,906 and                                        
  303,861,272 issued and outstanding at september 30, 2013 and december 31, 2012, respectively                                    8,260,010,000    
  shareholders’ equity                                        
  common shares, no par value, unlimited shares authorized, 332,455,182 and                                        
  303,861,272 issued and outstanding at june 30, 2013 and december 31, 2012, respectively                                     8,250,192,000   
  total shareholders’ equity                                     5,702,529,000 3,785,182,000  
  total liabilities and shareholders’ equity                                     19,782,258,000 14,146,208,000  
  marketable securities                                        
  income taxes payable                                      10,208,000 15,537,000 
  deferred revenue                                      18,142,000 7,031,000 
  common shares, no par value, unlimited shares authorized, 302,899,442 and                                        
  306,371,032 issued and outstanding at september 30, 2012 and december 31, 2011, respectively                                      5,916,671,000  
  shareholders' equity                                        
  common shares, no par value, unlimited shares authorized, 302,052,589 and                                        
  306,371,032 issued and outstanding at june 30, 2012 and december 31, 2011, respectively                                       5,885,225,000 
  total shareholders' equity                                       3,695,431,000 
  total liabilities and shareholders' equity                                       14,019,820,000 

We provide you with 20 years of balance sheets for Bausch Health Companies stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Bausch Health Companies. Explore the full financial landscape of Bausch Health Companies stock with our expertly curated balance sheets.

The information provided in this report about Bausch Health Companies stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.